Investor Presentaiton
Clearly Articulated Capital Allocation Priorities
Our Leading Portfolio Provides Significant Opportunity for Growth
$3.7B
2021 Announced
$1.4B
Investment Activity
Ongoing development principally
Senior Housing
in Life Science, R&I and Canadian
senior housing markets
70% of $3.7B
819 Communities
~$1B
Forward pipeline of Life
Science, R&I projects
47% Annualized Adjusted NOI
Historical Acquisition Volume
A
VENTASⓇ
Life Science, R&I
20% of $3.7B
43 Centers
+
Medical Office
10% of $3.7B
309 Buildings
10% Annualized Adjusted NOI
22% Annualized Adjusted NOI
Strong Track Record of External Investment
Experienced investments team, broad relationships and processes with
long track record of significant external growth
$12.0
$10.0
$8.0
$6.0
$4.0
$2.0
$-
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
>$3B Annual
Average 2011-2021
6000
2021
15View entire presentation